- Investing Ideas
- /
- Chinese Pharmaceuticals & Biotech Top Stock Picks from Analysts
Chinese Pharmaceuticals & Biotech Top Stock Picks from Analysts
Results
8
Companies which are more than 50% undervalued based on analyst price target.
8 companies
Haisco Pharmaceutical Group
Market Cap: CN¥60.2b
Researches, develops, manufactures, and sells pharmaceutical products in China.
002653
CN¥53.76
7D
-0.3%
1Y
45.5%
Dong-E-E-JiaoLtd
Market Cap: CN¥30.6b
Engages in the research, development, production, and sale of donkey-hide gelatin and other Chinese patent medicines in China.
000423
CN¥47.70
7D
1.1%
1Y
-22.7%
Nanjing King-Friend Biochemical PharmaceuticalLtd
Market Cap: CN¥17.0b
Nanjing King-Friend Biochemical Pharmaceutical Co.,Ltd.
603707
CN¥10.40
7D
-2.6%
1Y
-28.5%
Staidson (Beijing) BioPharmaceuticals
Market Cap: CN¥16.2b
Staidson (Beijing) BioPharmaceuticals Co., Ltd.
300204
CN¥33.65
7D
-7.3%
1Y
326.5%
Hunan Jiudian Pharmaceutical
Market Cap: CN¥8.2b
Researches, develops, produces, and sells pharmaceutical products in China and internationally.
300705
CN¥16.49
7D
-6.1%
1Y
-33.0%
Wedge IndustrialLtd
Market Cap: CN¥7.4b
Engages in the research and development, production, and sale of micro-ecological live bacteria products, superalloys, and related products in China.
000534
CN¥15.22
7D
-2.1%
1Y
34.9%
Hinova Pharmaceuticals
Market Cap: CN¥5.2b
A clinical-stage pharmaceutical company, engages in the development and production of therapeutics for cancers and metabolic syndromes.
688302
CN¥53.08
7D
-1.4%
1Y
47.9%
Beijing Kawin Technology Share-Holding
Market Cap: CN¥4.6b
A biopharmaceutical company, provides treatment solutions for viral and immune diseases in China.
688687
CN¥27.86
7D
-4.6%
1Y
-1.2%